OTLK icon

Outlook Therapeutics

81 hedge funds and large institutions have $6.11M invested in Outlook Therapeutics in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$106K
2 +$60.4K
3 +$57K
4
BlackRock
BlackRock
New York
+$39.3K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$29.8K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.08M
2
$1.39M
3
$617K
4
$615K
5
$278K
6
$115K
7
$96K
8
$78.4K
9
$74.8K
10
$70.8K
11
$57K
12
$42.8K
13
$40.9K
14
$34.1K
15
$32.8K
16
$32K
17
$30.1K
18
$28.5K
19
$23.9K
20
$22.9K
21
$22.4K
22
$22.3K
23
$17.1K
24
$16.5K
25
$14.8K